IL6 and neoplasm: Furthermore, reduced FTO in combination with m6A modification of APOE can modulate the IL-6/JAK2/STAT3 signaling pathway to promote tumor glycolysis, thereby aggravating the progression of PTC (Huang et al., 2022).